erythromycin
Generic: ERYTHROMYCIN·Brand: A/T/S, AKNE-MYCIN, BRISTAMYCIN, Benzamycin, C-SOLVE-2, E-BASE, E-GLADES, E-MYCIN, E-SOLVE 2, E.E.S., EMGEL, ERY-TAB, ERYC, ERYC 125, ERYC SPRINKLES, ERYCETTE, ERYDERM, ERYGEL, ERYMAX, ERYPAR, ERYTHRA-DERM, ERYTHRO-STATIN, ERYTHROCIN STEARATE, ERYTHROMYCIN, ERYTHROMYCIN STEARATE, ETHRIL 250, ETHRIL 500, Emcin Clear, Emgel, Ery, Ery-Tab, EryPed, Erygel, Erythrocin, Erythrocin Stearate, Eyemycin, ILOTYCIN, Maracyn, PCE, PFIZER-E, R-P MYCIN, ROBIMYCIN, SANSAC, STATICIN, T-STAT, Theramycin, WYAMYCIN S
erythromycin: 2 clinical trials tracked.
erythromycin evidence translation
What we can confirm
2 tracked trials
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about erythromycin, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence6 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (2)
Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management
Primary endpoint: Maternal Outcome
InterventionalRandomizedopen250 enrolledStarted 2024-04Completion 2025-031 site · PakistanDistrict Headquarters Teaching Hospital Sahiwal
Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors
Primary endpoint: Parts A, B, and D - Incidence of Treatment-Emergent Adverse Events (TEAEs) [Safety and Tolerability]
Interventionalopen952 targetStarted 2022-12Completion 2027-1066 sites · China, Japan, United StatesGenmab